The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

Mohammad Reza Zinatizadeh(Shahid Beheshti University of Medical Sciences), Bettina Schock(Queen's University Belfast), Ghanbar Mahmoodi Chalbatani(University of Tehran), Peyman Kheirandish Zarandi(Shahid Beheshti University of Medical Sciences), Seyed Amir Jalali(Shahid Beheshti University of Medical Sciences), Seyed Rouhollah Miri(University of Tehran)
Genes & Diseases
July 18, 2020
Cited by 553Open Access
Full Text

Abstract

The nuclear factor kappa B (NF-kB) family of transcription factors plays an essential role as stressors in the cellular environment, and controls the expression of important regulatory genes such as immunity, inflammation, death, and cell proliferation. NF-kB protein is located in the cytoplasm, and can be activated by various cellular stimuli. There are two pathways for NF-kB activation, as the canonical and non-canonical pathways, which require complex molecular interactions with adapter proteins and phosphorylation and ubiquitinase enzymes. Accordingly, this increases NF-kB translocation in the nucleus and regulates gene expression. In this study, the concepts that emerge in different cellular systems allow the design of NF-kB function in humans. This would not only allow the development for rare diseases associated with NF-kB, but would also be used as a source of useful information to eliminate widespread consequences such as cancer or inflammatory/immune diseases.


Related Papers

No related papers found

Powered by citation graph analysis